Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/115634
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK |
Author: | McEwan, P. Bennett, H. Ward, T. Webster, S. Gordon, J. Kalsekar, A. Yuan, Y. Brenner, M. |
Citation: | European Journal of Gastroenterology and Hepatology, 2016; 28(2):173-180 |
Publisher: | Lippincott Williams & Wilkins |
Issue Date: | 2016 |
ISSN: | 0954-691X 1473-5687 |
Statement of Responsibility: | Phil McEwan, Hayley Bennett, Thomas Ward, Samantha Webster, Jason Gordon, Anupama Kalsekar, Yong Yuan and Michael Brenner |
Abstract: | Abstract not available |
Keywords: | Phenotype |
Rights: | © 2016 Wolters Kluwer Health, Inc. All rights reserved. |
DOI: | 10.1097/MEG.0000000000000510 |
Published version: | http://dx.doi.org/10.1097/meg.0000000000000510 |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.